XOMA Royalty (XOMA) Operating Expenses (2011 - 2026)
XOMA Royalty's (XOMA) quarterly Operating Expenses came in at $12.8 million in Q1 2026, up 28.2% year-on-year from $10.0 million in Q1 2025, and up 10.57% quarter-over-quarter from $11.6 million in Q4 2025.
XOMA Royalty (XOMA) Operating Expenses (2011 - 2026) Analysis & Trends
XOMA Royalty has disclosed Operating Expenses across 16 years of filings, most recently posting $12.8 million for Q1 2026.
- Operating Expenses for Q1 2026 came in at $12.8 million, up 28.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $43.6 million (down 37.7% YoY), and the FY2025 annual result was $40.8 million, down 40.46% from the prior year.
- Operating Expenses came in at $12.8 million for Q1 2026 at XOMA Royalty, up from $11.6 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $22.8 million in Q3 2024 to a low of $4.8 million in Q3 2022.
- The 5-year median for Operating Expenses is $10.0 million (2025), against an average of $11.3 million.
- Across the five-year window, Operating Expenses soared 245.13% in 2024 and tumbled 59.72% in 2025, its largest moves.
- XOMA Royalty's Operating Expenses stood at $7.7 million in 2022, then surged by 182.84% to $21.8 million in 2023, then declined by 26.65% to $16.0 million in 2024, then fell by 27.51% to $11.6 million in 2025, then grew by 10.57% to $12.8 million in 2026.
- The last three Operating Expenses figures came in at $12.8 million (Q1 2026), $11.6 million (Q4 2025), and $10.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 15.76 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -67.40 Mn |
| 10 | XOMA Royalty | 5.52 Mn | -60.56 Mn | - | 12.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.80 Mn |
| Dec 31, 2025 | 11.58 Mn |
| Sep 30, 2025 | 10.68 Mn |
| Jun 30, 2025 | 8.53 Mn |
| Mar 31, 2025 | 9.98 Mn |
| Dec 31, 2024 | 15.97 Mn |
| Sep 30, 2024 | 22.84 Mn |
| Jun 30, 2024 | 21.17 Mn |
| Mar 31, 2024 | 8.49 Mn |
| Dec 31, 2023 | 21.77 Mn |
| Sep 30, 2023 | 6.62 Mn |
| Jun 30, 2023 | 7.62 Mn |
| Mar 31, 2023 | 10.61 Mn |
| Dec 31, 2022 | 7.70 Mn |
| Sep 30, 2022 | 4.82 Mn |
| Jun 30, 2022 | 5.75 Mn |
| Mar 31, 2022 | 5.17 Mn |
| Dec 31, 2021 | 5.58 Mn |
| Sep 30, 2021 | 4.29 Mn |
| Jun 30, 2021 | 3.97 Mn |